Advanced Filters
noise

Tokyo and Other Japanese City, Japan Clinical Trials

A listing of Tokyo and Other Japanese City, Japan clinical trials actively recruiting patients volunteers.

Found 65,447 clinical trials
J Josefine Gradman

Allergen Provocations- HCA Children's Hospital

A prospective study of all allergen provocations performed in children at the Hans Christian Andersen Children's Hospital.

- 18 years of age All Phase N/A

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

To obtain pregnancy outcome data from patients screened for fetal genetic status using non-invasive pregnancy testing (NIPT).

18 years of age Female Phase N/A
C Carola Lütgendorf-Caucig, MD MPH MBA

Ion Therapy Patient Registry

The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.

years of age All Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions

Objective: The objective of this study is to identify genetic causes of inherited eye conditions through whole exome or whole genome sequencing. This includes identifying mutations in known genes or novel genes for recognized conditions, as well as identifying mutations in novel genes for previously uncharacterized genetic conditions involving the …

1 - 120 years of age All Phase N/A
A Allison Moore

Natural History Study for Charcot Marie Tooth Disease

The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electronic Health Records (EHRs) and clinical notes to identify the burden, diagnostic journey, and prevalence of disease that will aid scientists in their work toward finding a cure. Participants …

years of age All Phase N/A
J Jiu-Yao Wang, MD

The Roles of Human Microbiome and Vitamin D in the Development of Childhood Allergic Diseases

A birth cohort study to evaluate the role of human microbiome and vitamin D in the development of allergic diseases in young child before one year of age.

- 1 years of age All Phase N/A
B Bruno Vellas, MD

The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform

Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC …

30 years of age All Phase N/A
Z Zhenzhen Liu, PhD

The Cohort Study of Pediatric Cataract

This retrospective-prospective bidirectional cohort study aims to observe ocular parameter changes, different surgical/vision recovery strategies and postoperative adverse effects among young children with cataract. The influence on psychology and cognitive function will be taken into consideration as well.

- 18 years of age All Phase N/A
F Feng Sun, doctor

Real-world Study Optimizing Nucleotide-analogues

The goal of this multicenter, observational, prospective study is to observe and compare different anti-viral treatment strategies in a real-world cohort of patients with CHB managed in routine clinical settings in China. The main questions it aims to answer are: To evaluate the benefits of initiating first-line nucleos(t)ide analogue in …

18 - 80 years of age All Phase N/A

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

This study is referred to as the "umbrella master protocol" for pembrolizumab (MK-3475) in the treatment of non-small cell lung cancer (NSCLC). This pembrolizumab NSCLC umbrella master protocol uses a platform design and consists of this master screening study and additional substudies. Each substudy will enroll a different population of …

18 years of age All Phase N/A

Simplify language using AI